Arafarma Group S.A. is a Spanish manufacturer that started as a Pharmaceutical Laboratory in 2003 and has rapidly evolved into a full-scale pharmaceutical manufacturer. The company's philosophy revolves around a deep understanding of pharmaceutical tradition, complemented by continuous development and innovation. Arafarma Group prides itself on its high standard of quality assurance, research, and up-to-date manufacturing technologies, ensuring the production of high-quality medications, food supplements, and OTC products.
As a company specializing in manufacturing non-sterile medications, food supplements and OTC products, contract manufacturing, clinical trials, and quality system consulting, Arafarma Group offers brand generics and innovative products. Their medications are notably sugar and glucose-free, catering to a niche market. Operating within the Urology, Gynecology, Dermatology, Traumatology, Rheumatology, and Cardiovascular fields, Arafarma Group delivers a full cycle of finished products manufactured according to GMP standards. Innovations aimed at generating added value for customers and patients are a cornerstone of the company's approach.
With its headquarters in Spain, Arafarma Group has shown promise in the manufacturing and pharmaceutical industries. Although the specific details regarding their latest investment, investors, or investment date remain undisclosed, Arafarma Group presents an intriguing investment opportunity within the pharmaceutical manufacturing sector, driven by its commitment to innovation and quality.
There is no investment information
No recent news or press coverage available for Arafarma Group S.A..
We care about your data, and we'd love to use cookies make your experience better.
